Revefenacin Peak Inspiratory Flow Rate (PIFR) Study in COPD

Clinical trial NCT03095456 · COMPLETED

Trial details

NCT number: NCT03095456
Sponsor: Mylan Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Chronic Obstructive Pulmonary Disease, COPD Low Peak Inspiratory Flow Rate (PIFR)

Start date: 2017-03-27
Primary completion: 2017-11-25
Enrollment: 207

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.